期刊文献+

不同抗凝方案治疗阵发性房颤的临床效果观察

原文传递
导出
摘要 我国房颤发生率大概在1%,70岁以上人群大概在3%~8%,抗凝治疗对房颤具有重要意义。资料显示[1],与无房颤人群相比,有房颤人群发生脑梗死的危险提高约5%以上。房颤是脑梗死的重要危险因素。本文探讨了不同抗凝方案治疗阵发性房颤的临床效果,报告如下。1对象与方法1.1对象选择2016年2月至2017年10月我院98例阵发性房颤患者,均经病史、ECG或Holter确诊。
作者 胡佳
出处 《中国冶金工业医学杂志》 2020年第4期446-446,共1页 Chinese Medical Journal of Metallurgical industry
  • 相关文献

参考文献2

二级参考文献18

  • 1中华医学会心血管病学分会,中华医学会心电生理和起搏分会,中国医师协会心律学专业委员会.非瓣膜病心房颤动患者新型口服抗凝药的应用中国专家共识[J].中华心律失常学杂志,2014,18:321-329.
  • 2Cappato R,Calkins H,Chen SA,et al. Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atri- al fibrillation[J]. Cireulation, 2005,111(9) : 1 100.
  • 3Dixit S,Marchlinski FE. How to recognize,manage,and prevent complications during atrial fibrillation ablation [J]. Heart Rhythm,2007,4(1) :108.
  • 4January CT,Wann LS, Alpetr JS, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atiral fibrillation, a report of the Ameirean College of Cardiology/American Heart Assoeiation Task Force on Practice Guidelines and the Heart Rhythm Soeiety[J]. Circulation, 2014,130 : e1 99.
  • 5Winkle RA, Mead RH, Engel G, et al. The use of dabigatran immediately after atrial fibrillation ablation [J]. J Cardiovasc Electrophysiol, 2012,23 : 264.
  • 6Provideneia R, Albeque JP, Combes S, et al. Safety and effeaey of dabigatran versus warfairn in patients undergoing catheter ablation of atrial fibrillation:a systematic review and meta-anal- ysis[J]. Hcart, 2014,100 : 324.
  • 7Bin Abdulhak AA,Khan AR,Tleyjeh IM, et al. Sfaety and eff- eacy of interrupted dabigatran for peri- procedural anticoagula- tion in catheter ablation of atrial fibrillation:a systematic review and meta -analysis[J]. Europace,2013,15 : 1 412.
  • 8Vazquez SR, Johnson SA, Rondina MT. Peri-proeedural antico- agulation in patients undergoing ablation for atrial fibrillation [J].Thromb Res,2010,126(2) :e69.
  • 9Viles-Goazalez JF, Mehta D. Thromboembolic risk and antico- agulation strategies in patients undergoing catheter ablation for atrial fibrillation[J]. Curr Cardiol Rep,2011,13(1) :38.
  • 10Takahashi A, Kuwahara T, Takahashi Y. Complications in the catheter ablation of atrial fibrillation: incidence and manage- ment[J]. Circ J,2009,73(2) :221.

共引文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部